BRST Labs redefines drug delivery through its patented sublingual absorption technology.

While access to generics has evolved, their delivery mechanisms haven't. Traditional methods such as gut absorption, intravenous (IV), and inhalation have limitations ranging from delayed effectiveness to health risks for patients.

The BRST™ Sublingual Tablet offers faster, more effective delivery, increasing bioavailability. Our drugs achieve maximum concentration within minutes, significantly outpacing their traditional counterparts.

BRST Labs applies this technology to Rx and OTC products across multiple therapeutic areas. To learn more about our solutions, contact us.